Incremental capacity analysis (dQ/dV) for utility-scale BESS review
Incremental capacity analysis is the clearest chemistry-fingerprint layer in the current Oxaide proof stack. In practical terms, it helps reviewers see whether a battery is aging the way the commercial story implies, especially in LFP-first utility BESS contexts.
What it shows
How the battery’s internal fingerprint shifts as it ages, separating healthy behaviour from fade, stress, and chemistry patterns that summary dashboards flatten away.
Why buyers care
It helps buyers test whether reported health, usable capacity, and downside assumptions are credible enough for pricing, reserves, and post-close plans.
Where it is strongest today
The strongest current public support is lithium-ion, especially LFP-first positioning anchored by Oxford and related literature lineage.
Buyer-safe framing
Incremental capacity analysis is not magic. It is a method layer that becomes valuable when the review question is commercial: is the asset condition clean enough for the pricing, underwriting, warranty, or operating story attached to it?
It should not be sold as universal proof across every chemistry and every fleet. The buyer-safe claim is narrower and stronger: it is a leading diagnostic layer in the current lithium-ion proof stack, with especially strong relevance for LFP-first utility BESS positioning.
That is exactly why it works well inside independent due diligence, warranty review, and post-COD checks: it gives a reviewer a more defensible physical read than summary State-of-Health numbers alone.